You just read:

Mirati Therapeutics Presents Data From Ongoing Clinical Trials Of Sitravatinib In Combination With Nivolumab At The SITC 34th Annual Meeting

News provided by

Mirati Therapeutics, Inc.

Nov 09, 2019, 18:15 ET